In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
The Supreme Court’s decision to invalidate many of President Trump’s tariffs raised questions about what would become of agreements struck with major U.S. trading partners.
The Supreme Court’s decision to invalidate many of President Trump’s tariffs raised questions about what would become of agreements struck with major U.S. trading partners.